Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) shares, rose in value on Thursday, April 16, with the stock price up by 2.23% to the previous day’s close as strong demand from buyers drove the stock to $10.53.
Actively observing the price movement in the last trading, the stock closed the session at $10.30, falling within a range of $10.11 and $10.66. The value of beta (5-year monthly) was 3.414. Referring to stock’s 52-week performance, its high was $45.00, and the low was $8.04. On the whole, ARCT has fluctuated by -21.42% over the past month.
With the market capitalization of Arcturus Therapeutics Holdings Inc currently standing at about $285.57 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-05.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 23.14M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ARCT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ARCT currently trading nearly -0.52% and -22.71% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.15, while the 7-day volatility ratio is showing 6.96% which for the 30-day chart, stands at 8.74%. Furthermore, Arcturus Therapeutics Holdings Inc (ARCT)’s beta value is 2.33, and its average true range (ATR) is 0.95.
A comparison of Arcturus Therapeutics Holdings Inc (ARCT) with its peers suggests the former has fared considerably weaker in the market. ARCT showed an intraday change of 2.23% in last session, and over the past year, it shrunk by -65.05%%.
Data on historical trading for Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) indicates that the trading volumes over the past 10 days have averaged 0.48 and over the past 3 months, they’ve averaged 434.93K. According to company’s latest data on outstanding shares, there are 27.00 million shares outstanding.
Nearly 10.14% of Arcturus Therapeutics Holdings Inc’s shares belong to company insiders and institutional investors own 89.84% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.65 million shares as on 2025-03-31, resulting in a short ratio of 11.6. According to the data, the short interest in Arcturus Therapeutics Holdings Inc (ARCT) stood at 2685.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 4.19 million. The stock has fallen by -37.95% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ARCT stock heading into the next quarter.
